Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.
Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce the appointment of former US Senate Majority Leader Tom Daschle as a Special Adviser to the Company. Joseph del Moral, Chief Executive Officer of Field Trip, said, “Senator Daschle has […]
MindMed Announces the Approval of Mescaline Study
BASEL, Switzerland , May 20, 2021 /PRNewswire/ — MindMed (Nasdaq:MNMD) (NEO:MMED) (DE:MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ethics committee of the first clinical trial evaluating the acute effects of different doses of mescaline and the role of the serotonin 5-HT2A receptor in mescaline-induced altered states of consciousness (MDR-Study). The […]
